June 20 (Reuters) – Vanc Pharmaceuticals Signs Definitive
Agreement For Exclusive In
The post BRIEF-Vanc Pharma signs agreement for in-license on a CAD $150m generic molecule and soon to be off patent molecule appeared first on NASDAQ.
BRIEF-Vanc Pharma signs agreement for in-license on a CAD $150m generic molecule and soon to be off patent molecule
